skirsch.io

Steve Kirsch is a prominent serial entrepreneur and advocate for drug repurposing, primarily focused on addressing the COVID-19 pandemic through innovative approaches. He has founded multiple high-tech companies and is known for his outspoken views on vaccine safety and public health. Motivated to make a difference during the COVID crisis, Kirsch invested $1 million of his own funds and raised an additional $5 million to launch the COVID Early Treatment Fund (CETF), with the goal of promoting early treatment options and supporting outpatient trials for repurposed drugs.

Through his platforms, including a Substack newsletter and public discussions, Kirsch provides insights into vaccine-related concerns, emphasizing transparency and accountability from health authorities. He has garnered attention for his investigations into vaccine injuries and has become a voice for those questioning mainstream narratives. By offering a space for dialogue and disseminating his findings, Kirsch aims to empower individuals with information and advocate for safer health solutions. Follow him on Substack to stay updated on his latest work and initiatives.